Trial of Maternal Diet Rich in Eggs and Peanuts and Infant Allergy Risk
Consuming a high-allergen maternal diet rich in eggs and peanuts during pregnancy and lactation does not reduce the incidence of IgE-mediated food allergies in infants by one year of age, according to a randomized controlled trial published in the New England Journal of Medicine (NEJM) on September 17, 2026. Led by researchers including Debra J. Palmer and Dianne E. Campbell, the multisite clinical trial investigated whether early in utero and breast milk exposure to common food allergens could induce immunological tolerance in high-risk infants, challenging previous hypotheses surrounding prenatal dietary interventions.
- The multisite trial assigned 2,137 pregnant women with a family history of allergic disease to either a high egg-peanut diet or a standard diet.
- At one year of age, 7.8% of infants in the high-exposure group developed egg or peanut allergies, compared to 8.4% in the control group, showing no statistically significant difference.
- Safety outcomes and adverse event profiles remained similar across both maternal diet groups throughout the study period.
Immune responses leading to food allergies often develop early in life, frequently before the introduction of solid foods. While early infant dietary interventions, such as those evaluated in investigations like the LEAP study published in the New England Journal of Medicine, demonstrated that introducing peanuts to infants can prevent peanut allergies, the window for effective immunological intervention remains under intense clinical scrutiny. Researchers hypothesized that maternal ingestion during gestation and lactation could prime the neonatal immune system via transplacental transfer and breast milk exposure. To test this, the trial enrolled pregnant women whose unborn children had at least two biologic family members with medically diagnosed allergic disease.
Participants were randomized in a 1:1 ratio into two distinct nutritional protocols before 23 weeks of gestation, continuing through four months postnatally during lactation. The high egg-peanut group consumed a diet featuring at least six eggs and 60 peanuts per week. Conversely, the standard-diet control group consumed no more than three eggs and 30 peanuts per week. Out of the total cohort, 1,070 participants were assigned to the high-exposure arm and 1,067 to the control arm.
The primary clinical endpoint measured IgE-mediated egg or peanut allergy in the infants at one year of age. Results showed that 83 of 1,066 infants (7.8%) in the maternal high egg-peanut group developed an allergy, compared to 89 of 1,064 infants (8.4%) in the standard-diet group. The relative risk stood at 0.93 with a 95% confidence interval ranging from 0.69 to 1.26, yielding a p-value of 0.65. These statistical metrics confirmed no significant divergence in allergy rates between the two cohorts.
The trial’s findings indicate that manipulating maternal intake of eggs and peanuts does not alter the trajectory of infant sensitization during the first year of life. Investigators noted that infant immune responses to foods like eggs and peanuts can sometimes be detected in the initial months of life before any direct dietary exposure occurs. This biological reality suggests that pathogenesis may begin earlier than previously conceptualized, potentially requiring alternative preventive strategies that target neonatal immune pathways directly.
Funding for the trial was provided by the Australian National Health and Medical Research Council and other supporting institutions, operating under the Australian New Zealand Clinical Trial Registry number ACTRN12618000937213. As clinical guidelines continue to evolve based on rigorous randomized controlled trial data, healthcare practitioners must counsel expectant parents using evidence-based parameters rather than dietary restriction or unverified prophylactic loading.
Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.